BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Filter
Active

Search results